Further investigations are needed to study the contribution of direct NR2F2:DNA binding to the modulation of ERα-dependent transcription in breast cancer cells, such as generating breast cancer cells with mutant DNA-binding domain of NR2F2 and the assessment of the transcriptional effect of such NR2F2 mutants. This evidence concerns the gene NR2F2 and breast carcinoma.